Impact of Uterine Leiomyoma Location on Uterine Artery Doppler Velocimetry
Key facts
- Who runs it
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 185 people enrolled
- Started
- 1 Oct 2024
- Ended
- 4 Jun 2025
- Type of study
- Observational, 4 groups
- Record updated
- 22 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- being older than 18 years old
- accepting the transvaginal ultrasound examination and having no impediment of having transvaginal ultrasound examination
- premenopausal status
- giving verbal and written consent to enroll
- being in the follicular phase of the menstrual cycle
Who cannot take part
- taking any of the hormonal drugs (such as oral contraceptives, levonorgestrel realisng intrauterine devices)
- not accepting the transvaginal ultrasound examination or having an impeding condition
- having a disease causing circulaiton abnormalities, cardiac diseases, or other comorbidities effecting circulation
- diagnosed diabetes
- diagnosed with any other gyneoclogical pathologies ( adenomyosis, endometriosis, adnexial masses, gynecologic malignancies, pelvic inflammatory diseases etc. )
- being younger than 18 years old
- pregnancy or postpartum status
- postmenopausal status
- being virgin
- being in the phases of menstrual cycle other than follicular phase
- diagnosis with type 2-5 and type 8 leiomyoma uteri according to the FIGO classification
- having multiple uterine leiomyomas
- having a uterine leiomyoma larger than 500cm3
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Aim: Investigation of the impact of uterine leiomyoma location on uterine artery velocimetry Materials and Methods: It is a single-center prospective cohort study. The information regarding patients' demography, medical history, obstetric history, menstrual patterns, gynecological history, patients' complaints and physical examination recorded. For the patients who experience pain, visual analog scores were recorded. Total number of 185 patients have been administered for this study. They are further divided into four sub-groups according to the leiomyoma location. All measurements were recorded by the same doppler ultrasonography machine and same preset settings were used for each measurement. All examinations were performed by the same investigator. The measurements of uterus and myoma in ortogonal projections were recorded to calculate the volume by the prolate elipsoid formula. The location of each myoma were noted according to the FIGO classification. The recorded doppler ultrasonography indices included pulsatility index, resistance index and sistol/diastol ratio. IBM SPSS 27.0.0 was used for statistical analysis.
Read full original descriptionShow less
Results: Mean values of PI, RI and S/D ratio were significantly lower in intramural myoma subgroup (p<0,01). The doppler parameters were significantly higher for submucousal myoma compared to intramural and subserous myoma groups (p<0,01) while there was no significant difference with control group. The impact of uterin leiomyoma location on uterin arter doppler findings were not altered by the effects of demographical features, age, BMI or history of c-section. The increased volumes of both uterus and myoma negatively correlated with the doppler indices while the history of c-section had a positive correlation with the doppler findings. The complaints of the patients at admission showed no effect on the doppler parameters.
Conclusion: The uterin leiomyoma location has been showed to be significant factor on uterin doppler velocimetry. The leiomyomas with intramural component significantly decreased the resistance in uterine artery. Further research is required to fully understand the underlying mechanism.
The 4 groups in the trial
- submucous leiomyoma
patients who are diagnosed with submucous leiomyoma
- intramural leiomyoma
patients who are diagnosed with intramural leiomyoma
- subserous leiomyoma
patients who are diagnosed with subserous leiomyoma
- control
patients in the control group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Uterine Leiomyoma Location on Uterine Artery Doppler Velocimetry : a Prospective Cohort Study
- Record updated
- 22 September 2025